Table 8.
VAS scores following leg extension
| Visit | AyuFlex1 (n = 56) | AyuFlex2 (n = 66) | Placebo (n = 50) | p value | ||||
|---|---|---|---|---|---|---|---|---|
| Overalla | AF1 + AF2 vs PBO | AF1 vs PBO | AF2 vs PBO | AF1 vs AF2 | ||||
| Overalla | 0.125 | 0.046 | 0.258 | 0.031 | 0.584 | |||
| 0 | 4.1 (±2.5) | 4.2 (±3.3) | 3.9 (±2.6) | |||||
| 14 | 3.6 (±2.3) | 4.2 (±3.3) | 3.7 (±2.8) | 0.966 | 0.409 | 0.463 | 0.088 | |
| 42 | 3.0 (±2.3) | 3.4 (±3.0) | 3.6 (±2.6) | 0.122 | 0.045 | 0.392 | 0.292 | |
| 84 | 2.2 (±2.1) | 2.3 (±2.9) | 3.1 (±2.5) | 0.010 | 0.010 | 0.033 | 0.668 | |
| Changes to Measures of VAS Score Following Leg Extensionb | ||||||||
| −1.9 (±2.2) | −1.8 (±2.5) | −0.8 (±2.5) | 0.048 | 0.039 | 0.022 | 0.043 | 0.717 | |
aOverall p value using mean changes over time amoung the listed group/s using a Repeated Measures ANCOVA
bThis was determined using Post Score Subtracted from Day 0
Values Presented as Mean ± Standard Deviation
Values determined to be significant (p = <0.05) indicated